Aptalis Pharma Canada ULC
Alberta Business Corporation · Calgary, Canada · LEI 254900BNZWFX2ZKCBL12
LEI active
Summary
Aptalis Pharma Canada ULC is registered in Canada and entered in the “Corporate Registry (Province of Alberta)” under number 2018260337. Its legal form is Alberta Business Corporation. According to GLEIF, its ultimate parent is ABBVIE INC. (United States), which is also its direct parent. That group has 64 subsidiaries with LEIs in 37 countries, 2 of them in Canada. The LEI was first issued on 3 Sep 2021 and the record was last updated on 18 May 2026; the next renewal is due by 18 May 2027. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2020, more than 24 months before this data release. The group may have changed since.
Company details
| Legal form | Alberta Business Corporation |
|---|---|
| Register | Corporate Registry (Province of Alberta) · Register website |
| Registration number | 2018260337 |
| Registration authority | Ministry of Service Alberta |
| Jurisdiction | Canada (CA-AB) |
| Registered address | 2400, 525-8th Avenue S.W., T2P 1G1 Calgary, Canada |
| Headquarters address | 597 Laurier Boulevard, J3H 6C4 Mont-Saint-Hilaire, Canada |
| Category | company or other legal entity |
| Status | active |
| Founded (per GLEIF) | 1 Jun 2014 |
| LEI | 254900BNZWFX2ZKCBL12 |
| LEI status | active |
| LEI first issued | 3 Sep 2021 |
| LEI record last updated | 18 May 2026 |
| Next LEI renewal | 18 May 2027 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Aptalis Pharma Canada ULC this entity
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | ABBVIE INC. | ABBVIE INC. |
| Accounting period | 2 Jan 2020 to 31 Dec 2020 | 2 Jan 2020 to 31 Dec 2020 |
| Evidence | other official documents | other official documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Consolidation percentage reported to GLEIF | 100.00% | 100.00% |
| Relationship start | 8 May 2020 | 8 May 2020 |
| Recorded at GLEIF since | 3 Sep 2021 | 3 Sep 2021 |
| Last updated | 10 Nov 2025 | 10 Nov 2025 |
| Record status | current | current |
Other subsidiaries of the same direct parent (59)
- AbbVie Corporation Canada
- AbbVie A/S Denmark lapsed
- AbbVie AG Switzerland lapsed
- AbbVie AS Norway lapsed
- AbbVie B.V. Netherlands lapsed
- AbbVie Bahamas Ltd. Bahamas lapsed
- AbbVie Biopharmaceuticals GmbH Switzerland
- ABBVIE BIOTECHNOLOGY LTD Bermuda
- AbbVie Central Finance B.V. Netherlands
- ABBVIE D.O.O. Slovenia lapsed
- AbbVie Deutschland GmbH And Co. KG Germany lapsed
- Abbvie Endocrine Inc. United States lapsed
History
27 Oct 2023Registered address changed